Mylène A. Carrascal
Impact in
- Immunology top 10%
- Immunotherapy and Immune Responses
- Galectins and Cancer Biology
- Biotechnology top 10%
- Cancer Research and Treatments
Papers in
-
- Glycosylation and Glycoproteins Research 13
- Immunology 15
- Immunotherapy and Immune Responses 11
- Galectins and Cancer Biology 3
- Co-authors
- Paula A. Videira (14 shared papers)Maria Teresa Cruz (15 shared papers)Bruno Miguel Neves (11 shared papers)Amílcar Falcão (8 shared papers)Célia Gomes (8 shared papers)Fabio Dall’Olio (6 shared papers)Paulo F. Severino (6 shared papers)Lúcio Lara Santos (4 shared papers)
- Journals
- Molecular Oncology (3 papers)BMC Cancer (2 papers)European Journal of Pharmaceutics and Biopharmaceutics (2 papers)International Journal of Molecular Sciences (2 papers)Pharmaceutics (2 papers)
- Partner nations
- PortugalItalyUnited States
In The Last Decade
Mylène A. Carrascal
28 papers receiving 745 citations
Peers
Comparison fields: 5 of 89
- Immunology 351
- Biotechnology 62
- Oncology 179
- Molecular Biology 446
- Immunology and Allergy 35
Countries citing papers authored by Mylène A. Carrascal
This map shows the geographic impact of Mylène A. Carrascal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mylène A. Carrascal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mylène A. Carrascal more than expected).
Fields of papers citing papers by Mylène A. Carrascal
This network shows the impact of papers produced by Mylène A. Carrascal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mylène A. Carrascal. The network helps show where Mylène A. Carrascal may publish in the future.
Co-authors
The 25 scholars most cited alongside Mylène A. Carrascal, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 89 | |
| 2 | 2020 | 80 | |
| 3 | 2013 | 73 | |
| 4 | 2015 | 64 | |
| 5 | 2017 | 53 | |
| 6 | 2022 | 43 | |
| 7 | 2019 | 39 | |
| 8 | 2020 | 37 | |
| 9 | 2012 | 32 | |
| 10 | 2021 | 27 | |
| 11 | 2019 | 27 | |
| 12 | 2018 | 25 | |
| 13 | 2011 | 21 | |
| 14 | 2017 | 18 | |
| 15 | 2024 | 14 | |
| 16 | 2018 | 14 | |
| 17 | 2021 | 14 | |
| 18 | 2021 | 13 | |
| 19 | 2021 | 13 | |
| 20 | 2018 | 11 |
About Mylène A. Carrascal
Mylène A. Carrascal is a scholar working on Molecular Biology, Immunology, Oncology, Radiology, Nuclear Medicine and Imaging and Biotechnology, having authored 29 papers that have together received 756 indexed citations. Recurring topics across this work include Glycosylation and Glycoproteins Research (13 papers), Immunotherapy and Immune Responses (11 papers), Cancer Research and Treatments (4 papers), Cell Adhesion Molecules Research (4 papers), CAR-T cell therapy research (4 papers), Monoclonal and Polyclonal Antibodies Research (4 papers), Galectins and Cancer Biology (3 papers) and Bladder and Urothelial Cancer Treatments (3 papers). The work is most often cited by research in Immunology (351 citations), Biotechnology (62 citations), Oncology (179 citations), Molecular Biology (446 citations) and Immunology and Allergy (35 citations). Mylène A. Carrascal has collaborated with scholars based in Portugal, Italy and United States. Frequent co-authors include Paula A. Videira, Maria Teresa Cruz, Bruno Miguel Neves, Amílcar Falcão, Célia Gomes, Fabio Dall’Olio, Paulo F. Severino, Lúcio Lara Santos, Mariana Silva and José S. Ramalho. Their work appears in journals such as Molecular Oncology, BMC Cancer, European Journal of Pharmaceutics and Biopharmaceutics, International Journal of Molecular Sciences and Pharmaceutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.